Skip to content 
Search

Latest Stories

Human brain continues forming neurons well into old age, study finds

The findings, published in the journal Science, provide fresh insight

Human brain continues forming neurons

Neurogenesis, the process by which new neurons form in the brain

iStock

Key points

  • New neurons continue forming in the brain’s hippocampus into old age
  • Study confirms presence of neural progenitor cells in adults
  • DNA carbon dating and single-nucleus RNA sequencing were used
  • Research shows variation in neuron production between individuals
  • Findings could aid treatments for neurodegenerative and psychiatric disorders

Human brain shows ongoing neuron formation into older age

A new study has confirmed that the human brain continues to produce new nerve cells well into late adulthood, challenging previous assumptions about age-related decline in neurogenesis. The findings, published in the journal Science, provide fresh insight into how adaptable the brain remains over a lifetime.

Neurogenesis, the process by which new neurons form in the brain, is known to occur in the hippocampus — a region involved in memory. While previous research has suggested that this process continues throughout life, there has been limited concrete evidence of the presence of neural progenitor cells in the adult brain.


Research confirms presence of progenitor cells

The study, conducted by researchers at the Karolinska Institutet in Sweden, confirms the existence of these progenitor cells — cells that develop into neurons — in the adult hippocampus. The team used DNA carbon dating to determine when the cells were formed. Brain tissue samples from people aged 0 to 78 were analysed, sourced from international biobanks.

“We have now been able to identify these cells of origin, which confirms that there is an ongoing formation of neurons in the hippocampus of the adult brain,” said Jonas Frisén, professor of stem cell research at the Karolinska Institutet, who led the study.

Advanced techniques reveal cell activity

To conduct the study, the researchers applied a method known as single-nucleus RNA sequencing, which allows scientists to analyse gene activity in individual cell nuclei. This was combined with machine learning to identify the different stages of neuron development, from stem cells to immature neurons.

The team identified all neural progenitor cell stages in early childhood samples. In adult samples, they located dividing progenitor cells using antibodies against the proliferation marker Ki67, alongside machine learning algorithms.

The results not only confirmed that adult neurogenesis takes place but also revealed that many of the dividing cells were in active developmental stages.

Significant variation between individuals

A notable finding from the study was the large variation in the presence of progenitor cells between individuals. While some adults had many such cells, others had very few. The researchers said this variability could have implications for understanding individual differences in brain ageing and cognitive resilience.

They also found that although the progenitor cells in humans were similar to those in animals such as mice, pigs, and monkeys, the active genes involved differed, suggesting some species-specific distinctions in brain development.

Implications for brain health and disease treatment

The findings provide valuable insight into how the human brain changes over time and could have medical implications. As many neurodegenerative diseases, such as Alzheimer’s, involve the loss of neurons in regions like the hippocampus, understanding how new neurons form could contribute to the development of regenerative therapies.

“This is an important piece of the puzzle in understanding how the human brain works and changes during life,” said Frisén. “It may also guide future treatment strategies for neurodegenerative and psychiatric conditions.”

PTI KRS KRS VN VN NNNN

More For You

Black women cancer risk

Serious public health challenges in the decades ahead

iStock

Study warns of rising uterine cancer rates, with Black women hardest hit

Key points

  • Uterine cancer cases and deaths are projected to rise significantly in the US by 2050.
  • Black women are expected to experience the highest increase in incidence-based mortality.
  • A new model predicts incidence rising to 86.9 cases per 100,000 for Black women and 74.2 for White women.
  • Researchers stress the urgent need for improved prevention and early detection strategies.

Sharp increase in uterine cancer predicted over next three decades

Uterine cancer, currently the fourth most commonly diagnosed cancer among women in the United States, is projected to see a substantial rise in both cases and deaths by 2050, particularly among Black women. A new study led by researchers at Columbia University warns of worsening racial disparities in outcomes if preventative measures are not introduced.

This year alone, around 69,120 new cases of uterine cancer and nearly 14,000 deaths are expected in the United States. However, projections by the Columbia University research team, published in Cancer Epidemiology, Biomarkers & Prevention, indicate a significant increase in both incidence and mortality over the next 30 years.

Keep ReadingShow less
Can dairy disrupt your sleep

The authors acknowledged potential limitations in their findings

iStock

Can dairy disrupt your sleep? Study links certain foods to nightmares

Key points

  • 40% of participants in a new study said food affects their sleep
  • Dairy and sweets were linked to worse sleep and more disturbing dreams
  • Fruit, herbal tea and vegetables were associated with better sleep quality
  • Authors suggest that lactose intolerance may play a role in dream disturbance

A recent study has explored how food may influence sleep and dreaming, with some participants reporting that certain items — particularly dairy and sweets — disrupted their rest and contributed to nightmares.

Study looked at food, sleep and dreams

The research, published in the journal Frontiers in Psychology on Monday, analysed responses from 1,082 college-aged participants who completed online surveys between January and April 2023. The survey asked about over a dozen food categories, including dairy, meat, fruit, desserts, and spicy foods.

Keep ReadingShow less
heatwave

The Met Office and UK Health Security Agency (UKHSA) have issued amber heat-health alerts

Getty Images

Doctors warn of hidden signs of heat stroke as UK issues amber alerts

Key points

  • Amber heat-health alerts issued as temperatures approach 35°C in parts of the UK.
  • Early signs of heat stroke include confusion, slurred speech, and dizziness.
  • Heat exhaustion can develop into heat stroke if not treated within 30 minutes.
  • At-risk groups include the elderly, young children, and those with health conditions.
  • NHS and health experts urge people to stay hydrated, cool, and avoid midday sun.

Medical experts are urging the public to remain alert for the early signs of heat stroke, as temperatures across parts of England are expected to reach up to 35°C. The Met Office and UK Health Security Agency (UKHSA) have issued amber heat-health alerts, warning that extreme heat can have serious health impacts. Doctors stress that symptoms can begin subtly, making early intervention crucial.

Heat alerts across multiple regions

Amber-level warnings are in effect for the West Midlands, East Midlands, Yorkshire and the Humber, South East, South West, London, and the East of England.

Keep ReadingShow less
weight loss injections UK

The importance of vigilance as demand for these weight loss and diabetes drugs continues to grow

iStock

Hundreds report pancreas issues linked to weight loss injections as UK launches safety study

Key points

  • Almost 400 reports of acute pancreatitis linked to weight loss and diabetes jabs have been filed in the UK
  • Most cases involve popular GLP-1 drugs including Ozempic, Wegovy, and Mounjaro
  • Health officials are investigating possible genetic causes behind the side-effects
  • Patients hospitalised with pancreatitis encouraged to report symptoms via MHRA’s Yellow Card scheme
  • Adverse drug reactions cost the NHS an estimated £2.2bn annually

Health watchdog investigates spike in serious side-effects from GLP-1 drugs

UK health authorities have launched a study into the side effects of popular weight loss and diabetes drugs following a spike in reported cases of acute pancreatitis. Nearly 400 reports have been received via the Medicines and Healthcare products Regulatory Agency’s (MHRA) Yellow Card scheme, which monitors side effects and adverse reactions related to medicines and medical devices.

The medicines involved are GLP-1 receptor agonists – including semaglutide (marketed as Ozempic and Wegovy), liraglutide, and tirzepatide (branded as Mounjaro). The Yellow Card data shows that 181 of the cases involved tirzepatide alone.

Keep ReadingShow less
Weight Loss Drug

Health officials expect the rollout to benefit around 220,000 adults over the next 3 years

iStock

NHS GPs to prescribe Mounjaro in nationwide obesity treatment plan

Key points

  • NHS GPs in England can now prescribe Mounjaro (tirzepatide) for weight loss
  • The programme aims to support 220,000 people over three years
  • Eligible patients must have a BMI over 40 and at least four obesity-related health issues
  • GP leaders raise concerns over increased workload
  • Pharmacists urge a broader weight management approach

NHS expands obesity treatment with Mounjaro

The NHS in England is set to begin prescribing Mounjaro, a weight loss injection, through GP surgeries starting Monday. The move marks the first time family doctors will be authorised to directly prescribe the anti-obesity drug tirzepatide as part of a wider national health initiative.

Health officials expect the rollout to benefit around 220,000 adults over the next three years. The drug will be made available to those with a body mass index (BMI) above 40 who also suffer from at least four other obesity-related conditions, such as type 2 diabetes, high blood pressure, or sleep apnoea.

Keep ReadingShow less